These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7307261)

  • 1. Stability of theophylline in serum, plasma, and saliva stored at different temperatures.
    Jonkman JH; Franke JP; Schoenmaker R; de Zeeuw RA
    Clin Chem; 1981 Dec; 27(12):2071-2. PubMed ID: 7307261
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring of theophylline treatment by saliva and plasma concentrations.
    Juntunen-Backman K; Backman A; Björkstén F; Finnilä MJ
    Allergol Immunopathol (Madr); 1988; 16(1):5-9. PubMed ID: 3381714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?
    Spigset O; Hägg S; Söderström E; Dahlqvist R
    Pharmacogenetics; 1999 Jun; 9(3):409-12. PubMed ID: 10471076
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between saliva and free and total plasma theophylline concentrations in patients with chronic airflow obstruction.
    Ebden P; Leopold D; Buss D; Smith AP; Routledge PA
    Thorax; 1985 Jul; 40(7):526-9. PubMed ID: 4035619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetic analysis of theophylline in serum and saliva.
    Trnavská Z; Rejholec V; Elis J; Spicák V
    Int J Clin Pharmacol Res; 1987; 7(5):329-35. PubMed ID: 3667005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of theophylline in serum and saliva in the presence of caffeine and its metabolites.
    Moncrieff J
    J Chromatogr; 1991 Jul; 568(1):177-85. PubMed ID: 1770095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of theophylline in human serum and whole blood.
    Johnson CE; Cohen IA; Bickley SK; Hyder DM
    Am J Hosp Pharm; 1984 Oct; 41(10):2065-8. PubMed ID: 6496497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring using oral samples collected with the OraSure device.
    Thieme T; Fitchen J; Bartos F; Salinsky M; Green T; Holden W
    Ann N Y Acad Sci; 1993 Sep; 694():337-9. PubMed ID: 8215082
    [No Abstract]   [Full Text] [Related]  

  • 9. Reliability of salivary theophylline as a guide to plasma theophylline levels.
    Galant SP; Gillman SA; Cummins LH; Kozak PP; Orcutt JJ
    Am J Dis Child; 1977 Sep; 131(9):970-2. PubMed ID: 900084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monitoring serum theophylline levels in children. Use of saliva for prediction].
    Dolezalová K; Martínková J; Kopecká J; Kuralová Z; Etlerová E
    Cesk Pediatr; 1989 Oct; 44(10):592-6. PubMed ID: 2620353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.
    Knott C; Bateman M; Reynolds F
    Br J Clin Pharmacol; 1984 Jan; 17(1):9-14. PubMed ID: 6691893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma and stimulated-saliva concentrations of theophylline in asthmatic children.
    Krivoy N; Zinman P; Hoffer E; Teitelman U; Rubin A
    Pharmatherapeutica; 1985; 4(5):285-7. PubMed ID: 4070321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of saliva for monitoring theophylline concentrations.
    Rylance GW; Beswick DT; Cullen RE; Roberts DG
    Arch Dis Child; 1985 Jan; 60(1):66-8. PubMed ID: 3970575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of saliva and plasma theophylline levels following single dose administration of two sustained release preparations.
    Jackson AH; Edwards C; Cope AS; Stockley RA; Purkiss R
    Br J Clin Pharmacol; 1983 Apr; 15(4):407-10. PubMed ID: 6849775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva-serum theophylline concentrations: substantial intrapatient and interpatient variation in predicting serum concentrations.
    Uden DL; Miller KW; Strand LM; Johnson PB; Zaske DE
    Ther Drug Monit; 1981; 3(2):143-50. PubMed ID: 7268827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
    Bochsler HP; Meyer UA
    Schweiz Med Wochenschr; 1982 Nov; 112(47):1702-10. PubMed ID: 7178872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of salivary concentrations in the prediction of serum caffeine and theophylline concentrations in premature infants.
    Khanna NN; Bada HS; Somani SM
    J Pediatr; 1980 Mar; 96(3 Pt 1):494-9. PubMed ID: 7359248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect plasma-theophylline monitoring in asthmatic children by determination of theophylline concentration in saliva.
    Levy G; Ellis EF; Koysooko R
    Pediatrics; 1974 Jun; 53(6):873-6. PubMed ID: 4832429
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma-saliva ratio of theophylline following oral theophylline derivatives [proceedings].
    Boobis S; Trembath PW
    Br J Clin Pharmacol; 1978 Nov; 6(5):456P-457P. PubMed ID: 728307
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma.
    Aviram M; Tal A; Ben-Zvi Z; Gorodischer R
    Pediatrics; 1987 Dec; 80(6):894-7. PubMed ID: 3684402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.